These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8094492)

  • 1. Increased nitric oxide synthesis in ulcerative colitis.
    Middleton SJ; Shorthouse M; Hunter JO
    Lancet; 1993 Feb; 341(8843):465-6. PubMed ID: 8094492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis.
    Perner A; Andresen L; Normark M; Fischer-Hansen B; Sørensen S; Eugen-Olsen J; Rask-Madsen J
    Gut; 2001 Sep; 49(3):387-94. PubMed ID: 11511561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
    Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
    Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
    Sharon P; Ligumsky M; Rachmilewitz D; Zor U
    Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
    Boughton-Smith NK; Evans SM; Hawkey CJ; Cole AT; Balsitis M; Whittle BJ; Moncada S
    Lancet; 1993 Aug; 342(8867):338-40. PubMed ID: 7687730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis.
    Gertner DJ; Rampton DS; Stevens TR; Lennard-Jones JE
    Aliment Pharmacol Ther; 1992 Apr; 6(2):163-8. PubMed ID: 1318088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide concentrations of rectal mucosa in ulcerative colitis.
    Zlatkina AR; Belousova EA; Vinitsky LI; Avtandilov GG; Chervonnaya LV
    Scand J Gastroenterol; 1990 Apr; 25(4):341-4. PubMed ID: 2159653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants.
    Parker N; Tsai HH; Ryder SD; Raouf AH; Rhodes JM
    Digestion; 1995; 56(1):52-6. PubMed ID: 7895933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.
    Rachmilewitz D; Eliakim R; Ackerman Z; Karmeli F
    Am J Gastroenterol; 1998 Mar; 93(3):409-12. PubMed ID: 9517649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine.
    Lee QP; Juchau MR
    Teratology; 1994 Jun; 49(6):452-64. PubMed ID: 7538231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode.
    Iwashita E
    J Gastroenterol Hepatol; 1998 Apr; 13(4):391-5. PubMed ID: 9641303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis.
    Zhang YJ; Xu JJ; Wang P; Wang JL
    Genet Mol Res; 2014 Dec; 13(4):10837-51. PubMed ID: 25526204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis.
    Santhanam S; Rajamanickam S; Motamarry A; Ramakrishna BS; Amirtharaj JG; Ramachandran A; Pulimood A; Venkatraman A
    Inflamm Bowel Dis; 2012 Nov; 18(11):2158-68. PubMed ID: 22374887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein.
    Cirillo C; Sarnelli G; Esposito G; Grosso M; Petruzzelli R; Izzo P; Calì G; D'Armiento FP; Rocco A; Nardone G; Iuvone T; Steardo L; Cuomo R
    Neurogastroenterol Motil; 2009 Nov; 21(11):1209-e112. PubMed ID: 19558426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide.
    Denham S; Rowland IJ
    Clin Exp Immunol; 1992 Jan; 87(1):157-62. PubMed ID: 1733631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
    Fryburg DA
    J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
    Naess PA; Kirkebøen KA; Christensen G; Kiil F
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F939-42. PubMed ID: 1535755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
    Winn MJ; Asante NK; Ku DD
    J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.